Role of the M3 muscarinic acetylcholine receptor subtype in murine ophthalmic arteries after endothelial removal

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 1, 2014, Pages 625-631

  Gericke, Adrian ^a   Steege, Andreas ^b   Manicam, Caroline ^a   Böhmer, Tobias ^a   Wess, Jürgen ^c   Pfeiffer, Norbert ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c National Institutes of Health   (Germany)

Author keywords

Acetylcholine; Mice; Muscarinic receptors; Ophthalmic arteries; Vasoconstriction

Indexed keywords

ACETYLCHOLINE; ATROPINE; CARBACHOL; COMPLEMENTARY DNA; MESSENGER RNA; MUSCARINIC M3 RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CORNEAL ENDOTHELIAL CELL LOSS; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPHTHALMIC ARTERY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE ANALYSIS; VASOCONSTRICTION; VIDEO MICROSCOPY; VISUAL SYSTEM FUNCTION; VISUAL SYSTEM PARAMETERS; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; MUSCARINIC RECEPTORS; OPHTHALMIC ARTERIES; PATHOPHYSIOLOGY; RETINA DISEASE; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; MICE; MUSCARINIC RECEPTORS; OPHTHALMIC ARTERIES; VASOCONSTRICTION;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; OPHTHALMIC ARTERY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MUSCARINIC M3; RETINAL DISEASES; RNA, MESSENGER; VASOCONSTRICTION;

EID: 84893158618     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13549     Document Type: Article

References (48)

1. Caulfield MP, Birdsall NJ. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279-290.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcho-line. Nature. 1980;288:373-376.
3. Faraci FM, Sigmund CD. Vascular biology in genetically altered mice: smaller vessels, bigger insight. Circ Res. 1999;85:1214-1225.
4. Zagvazdin Y, Fitzgerald ME, Reiner A. Role of muscarinic cholinergic transmission in Edinger-Westphal nucleus-induced choroidal vasodilation in pigeon. Exp Eye Res. 2000;70:315-327.
5. Gericke A, Mayer VG, Steege A, et al. Cholinergic responses of ophthalmic arteries in M3 and M5 muscarinic acetylcholine receptor knockout mice. Invest Ophthalmol Vis Sci. 2009;50: 4822-4827.
6. Gericke A, Sniatecki JJ, Goloborodko E, et al. Identification of the muscarinic acetylcholine receptor subtype mediating cholinergic vasodilation in murine retinal arterioles. Invest Ophthalmol Vis Sci. 2011;52:7479-7484.
7. Savage HI, Hendrix JW, Peterson DC, Young H, Wilkinson CP. Differences in pulsatile ocular blood flow among three classifications of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:4504-4509.
8. Pournaras CJ, Logean E, Riva CE, et al. Regulation of subfoveal choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:1581-1586.
9. Kaup M, Plange N, Arend KO, Remky A. Retrobulbar haemodynamics in non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol. 2006;90:1350-1353.
10. Emre M, Orgul S, Gugleta K, Flammer J. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation. Br J Ophthalmol. 2004;88:662-666.
11. Fujii K, Heistad DD, Faraci FM. Effect of diabetes mellitus on flow-mediated and endothelium-dependent dilatation of the rat basilar artery. Stroke. 1992;23:1494-1498.
12. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001; 88:E14-E22.
13. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 1987;327:237-239.
14. Luscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension. 1987;9: 193-197.
15. Treasure CB, Manoukian SV, Klein JL, et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 1992;71:776-781.
16. 0 -monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest. 1987;79:170-174.
17. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051.
18. Thorin E. Influence of nitric oxide synthase inhibition and endothelin-1 receptor blockade on acetylcholine-induced coronary artery contraction in vitro in dilated and ischemic cardiomyopathies. J Cardiovasc Pharmacol. 2001;38:90-98.
19. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 1986;8:344-348.
20. Malecki MT, Osmenda G, Walus-Miarka M, et al. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction. Eur J Clin Invest. 2008;38:925-930.
21. Resch H, Garhofer G, Fuchsjager-Mayrl G, Hommer A, Schmetterer L. Endothelial dysfunction in glaucoma. Acta Ophthalmol. 2009;87:4-12.
22. Watson N, Daniels DV, Ford AP, Eglen RM, Hegde SS. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells. Br J Pharmacol. 1999;127:590-596.
23. Yamada M, Miyakawa T, Duttaroy A, et al. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature. 2001;410:207-212.
24. Pradidarcheep W, Labruyere WT, Dabhoiwala NF, Lamers WH. Lack of specificity of commercially available antisera: better specifications needed. J Histochem Cytochem. 2008;56:1099-1111.
25. Jositsch G, Papadakis T, Haberberger RV, Wolff M, Wess J, Kummer W. Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice. Naunyn Schmiede-bergs Arch Pharmacol. 2009;379:389-395.
26. Osol G, Cipolla M, Knutson S. A new method for mechanically denuding the endothelium of small (50-150 microns) arteries with a human hair. Blood Vessels. 1989;26:320-324.
27. Buckley CH, Hadoke PW, O'Brien CJ. Role of the endothelium in modulating functional responses of isolated bovine anterior ciliary arteries to vasoconstrictor agonists. Br J Ophthalmol. 1998;82:826-829.
28. Gericke A, Kordasz ML, Steege A, et al. Functional role of alpha1-adrenoceptor subtypes in murine ophthalmic arteries. Invest Ophthalmol Vis Sci. 2011;52:4795-4799.
29. Hoste AM, Andries LJ. Contractile responses of isolated bovine retinal microarteries to acetylcholine. Invest Ophthalmol Vis Sci. 1991;32:1996-2005.
30. Angus JA, Campbell GR, Cocks TM, Manderson JA. Vasodila-tation by acetylcholine is endothelium-dependent: a study by sonomicrometry in canine femoral artery in vivo. J Physiol. 1983;344:209-222.
31. Yao K, Tschudi M, Flammer J, Luscher TF. Endothelium-dependent regulation of vascular tone of the porcine ophthalmic artery. Invest Ophthalmol Vis Sci. 1991;32:1791-1798.
32. Simonsen U, Prieto D, Rivera L, Hernandez M, Mulvany MJ, Garcia-Sacristan A. Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries. Br J Pharmacol. 1993;109:998-1007.
33. Dauphin F, Linville DG, Hamel E. Cholinergic dilatation and constriction of feline cerebral blood vessels are mediated by stimulation of phosphoinositide metabolism via two different muscarinic receptor subtypes. J Neurochem. 1994;63:544-551.
34. Shimizu T, Rosenblum WI, Nelson GH. M3 and M1 receptors in cerebral arterioles in vivo: evidence for downregulated or ineffective M1 when endothelium is intact. Am J Physiol. 1993;264:H665-H669.
35. Norel X, Walch L, Costantino M, et al. M1 and M3 muscarinic receptors in human pulmonary arteries. Br J Pharmacol. 1996;119:149-157.
36. Ren LM, Nakane T, Chiba S. Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J Cardiovasc Pharmacol. 1993;22:841-846.
37. Obi T, Kabeyama A, Nishio A. Characterization of muscarinic receptor subtype mediating contraction and relaxation in equine coronary artery in vitro. J Vet Pharmacol Ther. 1994; 17:226-231.
38. Luscher TF, Boulanger CM, Dohi Y, Yang ZH. Endothelium-derived contracting factors. Hypertension. 1992;19:117-130.
39. Boulanger CM, Morrison KJ, Vanhoutte PM. Mediation by M3-muscarinic receptors of both endothelium-dependent contraction and relaxation to acetylcholine in the aorta of the spontaneously hypertensive rat. Br J Pharmacol. 1994;112: 519-524.
40. Okubo H, Gherezhiher T, Koss MC. Long posterior ciliary arterial blood flow and systemic blood pressure. Invest Ophthalmol Vis Sci. 1990;31:819-826.
41. Mann RM, Riva CE, Stone RA, Barnes GE, Cranstoun SD. Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci. 1995;36:925-930.
42. Shaikh MH, Mars JS. The acute effect of pilocarpine on pulsatile ocular blood flow in ocular hypertension. Eye (Lond). 2001;15:63-66.
43. Elhusseiny A, Hamel E. Muscarinic-but not nicotinic-acetyl-choline receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype. J Cereb Blood Flow Metab. 2000;20:298-305.
44. Yamada M, Lamping KG, Duttaroy A, et al. Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A. 2001;98:14096-14101.
45. Bruning TA, Hendriks MG, Chang PC, Kuypers EA, van Zwieten PA. In vivo characterization of vasodilating muscarin-ic-receptor subtypes in humans. Circ Res. 1994;74:912-919.
46. Gericke A, Sniatecki JJ, Mayer VG, et al. Role of M1, M3, and M5 muscarinic acetylcholine receptors in cholinergic dilation of small arteries studied with gene-targeted mice. Am J Physiol Heart Circ Physiol. 2011;300:H1602-1608.
47. Stewart GD, Sexton PM, Christopoulos A. Prediction of functionally selective allosteric interactions at an M3 musca-rinic acetylcholine receptor mutant using Saccharomyces cerevisiae. Mol Pharmacol. 2010;78:205-214.
48. Stewart GD, Sexton PM, Christopoulos A. Detection of novel functional selectivity at M3 muscarinic acetylcholine receptors using a Saccharomyces cerevisiae platform. ACS Chem Biol. 2010;5:365-375.